Drug Profile
Research programme: gene therapies - Enzo Biochem
Latest Information Update: 28 Apr 2023
Price :
$50
*
At a glance
- Originator Enzo Biochem; Enzo Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Eye disorders; Gastrointestinal disorders; Metabolic disorders
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
- 28 Apr 2023 No recent reports of development identified for preclinical development in Eye-disorders in USA (Parenteral)
- 28 Apr 2023 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in USA (Parenteral)